The 2002 annual work programme defines the projects to be undertaken in the various thematic areas outlined in the 2001–03 work programme and continues to work on implementing the goals and objectives set out within it. The content of the work programme is consistent with the aims, principles and priorities outlined in the 2001–03 work programme. It concentrates on monitoring the drug situation; monitoring responses to the drug problem; implementing the 1997 Joint action on new synthetic drugs; and monitoring national and Community strategies and policies and their impact on the drug situation. These activities are supported by dissemination and administrative initiatives and by the Reitox network of national focal points. Special attention is also devoted to EU enlargement in accordance with the 'Enlargement strategy' adopted by the Management Board. A budget of EUR 9 412 500 was adopted for the implementation of the 2002 work programme. Of this, 33 % of the resources are earmarked for monitoring the drug situation; 28 % for monitoring responses; 15 % for the REITOX network; 15 % for monitoring strategies and their impact; and 9 % for implementing the Joint action on new synthetic drugs. A further EUR 943 861 is provided by an EC specific fund for the 2002 phase of the Phare-EMCDDA project to prepare the integration into the EMCDDA of the candidate CEECs.